glp-1 obesity drug market forecast 2030 Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Receptor Agonists Obesity Drugs

Novo Nordisk has launched its own telehealth programme for regular-dose semaglutide through its own channels, as well as other providers, for $499 per month, although a partnership with Hims & Hers quickly broke down due to what the company said were "concerns about [] illegal mass compounding and deceptive marketing." Hims & Hers which accused Novo Nordisk of 'anticompetitive' actions is now offering a compounded version at $199 per month.

Jardiance (empagliflozin) Discover Savings on Your Medication Access Trusted concierge service, secure process, and real savings for patients in the U.S

The FDA noted that it had received over 1000 reports of adverse events arising from compounded GLP-1 dosing errors and unapproved ingredients and suggested that such adverse events are likely underreported due to the limited application of federal regulations to state-licensed pharmacies

Metabolism Ignite is not just another supplement claiming to be a natural GLP-1. It was born by years of direct testing of hormones and 20 years of research into synergistic plant compounds, says Allie Egan, certified hormonal health coach and founder and CEO of Veracity Self-Care, a wellness brand that specializes in at-home hormone testing and supplementation

For consumer goods companies, this represents both a challenge and an opportunity

Psychiatry 10, 313323